Journals / Journal of Contemporary Medicine / 2021 / Cilt: 11 - Sayı: 3

A Study on Factors Impacting Length of Hospital Stay of COVID-19 Inpatients

COVID-19 Tanısı ile Hastanede Yatan Hastalarda Hastanede Kalış Süresini Etkileyen Faktörler Üzerine Bir Araştırma

Pages
396–404
Publication Date
2021-05-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By using simple, conditional and cause-specific Cox proportional-hazard regressions for competing risk, we examined factors impacting hospital stay time, both overall and by taking into account patient’s age or survival status and contribution from a factor to the rate of event of mortality, and to the event of discharge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Knowing the typical length of hospital stay of COVID-19 patients and which factors affecting the stay time is important for hospital management. 3184 COVID-19 patients from the Tokat State Hospital collected from were examined on arrival to the hospital and were either treated as inpatients, or as outpatients.
📊
Key Findings & Data:By using simple, conditional and cause-specific Cox proportional-hazard regressions for competing risk, we examined factors impacting hospital stay time, both overall and by taking into account patient’s age or survival status and contribution from a factor to the rate of event of mortality, and to the event of discharge.
💡
Conclusion & Impact:This information could be used for a better hospital bed management.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Demografik ve Klinik Faktörler · Cox orantılı hazard modeli

Abstract

Knowing the typical length of hospital stay of COVID-19 patients and which factors affecting the stay time is important for hospital management. 3184 COVID-19 patients from the Tokat State Hospital collected from were examined on arrival to the hospital and were either treated as inpatients, or as outpatients. By using simple, conditional and cause-specific Cox proportional-hazard regressions for competing risk, we examined factors impacting hospital stay time, both overall and by taking into account patient’s age or survival status and contribution from a factor to the rate of event of mortality, and to the event of discharge. Surviving ICU patients have longer hospital stay time than non-surviving ICU patients, which is longer than non-ICU patients. Older age is correlated with a longer hospital stay. Increased C-reactive protein (CRP), decreased hemoglobin (HGB) and calcium levels are associated with longer hospital stay, independent from the contribution from surviving status. Almost all factors we collected contribute to a faster/slower mortality or discharge rate. We also observed that glucose is more important than HbA1C or diabetes status in its influence on hospital stay time. This information could be used for a better hospital bed management.

Özet

COVID-19 hastalarının hastanede kalış süreleri ve kalış sürelerini etkileyen faktörlerin belirlenmesi hastane yönetimi için önem arz etmektedir. Tokat Devlet Hastanesin’e başvuran 3184 COVID-19 hastası hastaneye gelişlerinde muayene edilip ayakta veya yatarak tedavi edilmelerine göre kategorize edildiler. Basit, koşullu ve yarışan riskler için Cox orantılı hazard modeli kullanılarak, hem genel olarak ve hem de hastanın yaşı veya hayatta kalma süresi bir faktörün ölüm oranına ve taburcu olma durumuna katkısı dikkate alınarak, hastanede kalış sürelerini etkileyen faktörler incelendi. Hayatta kalan Yoğun Bakım Ünitesi hastalarının, hayatta kalmayan Yoğun Bakım Ünitesi hastalarına ve Yoğun Bakım Ünitesi olmayan hastalara göre daha uzun hastanede kalış süresine sahip olduğu bulgulandı. Artan yaşın, hastanede daha uzun kalış süresiyle ilişkili olduğu gözlemlendi. Yüksek C-reaktif protein (CRP), düşük hemoglobin (HGB) ve kalsiyum seviyelerinin, hayatta kalma durumunun katkısından bağımsız olarak, hastanede daha uzun kalma süresiyle ilişkili olduğu belirlendi. Çalışmamızda hemen hemen bütün faktörlerin daha hızlı / daha yavaş ölüm veya taburcu olma oranına katkıda bulunduğu gözlemlenmiştir. Ayrıca, glukozun, hastanede kalış süresi ile ilgili olarak, HbA1C veya diyabet durumundan daha önemli olduğu gözlemlendi. Bu bulguların, daha iyi bir hastane yatak yönetimi için kullanılabileceğini düşünmekteyiz.

🔖

Cite This Article

ÇETİN, Ş., ULGEN, A., ŞIVGIN, H., Lİ, W. (2021). A Study on Factors Impacting Length of Hospital Stay of COVID-19 Inpatients. Journal of Contemporary Medicine, Cilt: 11 - Sayı: 3, 396–404. https://ajindex.com/articles/775025

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Brown TM. The COVID-19 pandemic in historical perspective: an AJPH dossier, Am. J. Pub. Health 2021
  2. Allison P. Event History Analysis: Regression for Longitudinal Event Data, 2nd edition, (SAGE Publications)
  3. Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks, Circulation 2016
  4. Colquhoun D. The reproducibility of research and the misinterpretation of p-values, Royal Soc. Open Sci. 2017
  5. 171085. (5) Ioannidis JPA. The proposal to lower P value thresholds to. 005, JAMA 2018
  6. Li W, Shih A, Freudenberg-Hua Y, Fury W, Yang Y. Beyond standard pipeline and p (7) Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions, J. Clin. Epid. 2013
  7. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data, Am. J. Epid. 2009
  8. Putter H, Schmacher M, Van Houwelingen HC. On the relation between the causespecific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited, Biometrical J. 2020
  9. Fine JP and Gray RJ. A proportional hazards model for the subdistribution of a competing risk, J. Am. Stat. Asso. 1999
  10. McInnes L, Healy J, Saul N, Grossberger L. UMAP: uniform manifold approximation and projection, J. Open Source Software 2018
  11. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations, Clinc. Res. Rev.2020
  12. Skwieresky S, Rosengarten S, Change M, Thomson A, Meisel T, Macaluso F, Da Silva B, Oommen A, Banerji MA. Sugar is not always sweet: exploring the relationhsip between hyperglycemia and COVID- 19 in a predominantly African American population, abstract ENDO2021 (Mar 20-23, 2021, Endocrine Society), 2021. (14) Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, Jabaley CS, on behalf of the Emory COVID-19 Quality & Clinical Research Collaborative. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19, PLoS ONE 2020
  13. e0242400. (15) Nemer DM, Wilner BR, Burkle A, Aguilera J, Adewumi J, Gillombardo C, Wazni O, Menon V, Pengel S, Foxx M, Petre M, Hamilton AC, Cantillon DJ. Clinical characteristics and outcomes of Non-ICU hospitalization for COVID-19 in a nonepicenter, centrally